SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-079246
Filing Date
2022-12-13
Accepted
2022-12-12 20:14:32
Documents
14
Period of Report
2022-12-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170063-8k_inmedpharma.htm   iXBRL 8-K 35137
2 LETTER FROM KPMG LLP DATED DECEMBER 12, 2022 ea170063ex16-1_inmedpharma.htm EX-16.1 4428
3 GRAPHIC ex16-1_001.jpg GRAPHIC 1969
  Complete submission text file 0001213900-22-079246.txt   221248

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20221208.xsd EX-101.SCH 3233
5 XBRL LABEL FILE inm-20221208_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20221208_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea170063-8k_inmedpharma_htm.xml XML 3741
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221458316
SIC: 2834 Pharmaceutical Preparations